Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05004636 · ClinicalTrials.gov registry record · NA

Adductor Canal Blocks With Bupivacaine and Magnesium After Same-day Discharge Total Knee Arthroplasty Improve Post-operative Pain Relief and Decrease Opioid Consumption: a Prospective Randomized Controlled Trial

A NA study of Postoperative Pain, Acute, sponsored by Wayne State University.

Completed
Registry status
NA
Development phase
119
Enrollment target
1
Study location

NCT05004636: Completed NA study of Postoperative Pain, Acute, sponsored by Wayne State University.

NCT05004636 is a NA study of Postoperative Pain, Acute that has completed, run by Wayne State University. The registered enrollment target is 119 participants, below the 189-participant average among 7 other Postoperative Pain, Acute trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05004636, a NA study of Postoperative Pain, Acute, has completed, sponsored by Wayne State University.

COMPLETED
Registry status
NA
Development phase
119 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether the addition of magnesium to bupivacaine for the post-operative adductor canal blocks (ACB) can decrease opioid consumption and improve pain management for patients after same-day discharge total knee arthroplasty (TKA). The investigators will assess whether the addition of magnesium will decrease visual analog scale (VAS) pain scores, decrease post-operative total opioid consumption (oral morphine equivalents), decrease the incidence of post-operative nausea and vomiting (PONV), and improve patient satisfaction in comparison to when magnesium is not administered.

Primary Outcome

Measuring the post surgical total opioid consumption in the first 24 hours after surgery by calculating oral morphine equivalents (mg)

Conditions Studied

Interventions

  • DRUG Adding Magnesium as an adjuvant to the adductor canal Block (ACB) for same-day discharge total knee arthroplasty

Study Locations (1)

Michigan

  • St. Joseph Mercy Oakland Hospital - Pontiac

Trial Details

FieldValue
Enrollment Target 119 participants
Start Date 2020-08-05
Est. Completion 2021-05-29
Phase NA
Wayne State University

163 total trials

What the finished NCT05004636 record still lists

NCT05004636 is an interventional study that assigns participants to a tested intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap, below the 189-participant average among 7 other Postoperative Pain, Acute trials with a reported enrollment target (37% lower).

The record links to 1 condition, with Postoperative Pain, Acute appearing as the primary indexed condition, and to 1 intervention - of which Adding Magnesium as an adjuvant to the adductor canal Block (ACB) for same-day discharge total knee arthroplasty is the first listed.

NCT05004636 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT05004636 about?

NCT05004636 is a clinical study titled "Adductor Canal Blocks With Bupivacaine and Magnesium After Same-day Discharge Total Knee Arthroplasty Improve Post-operative Pain Relief and Decrease Opioid Consumption: a Prospective Randomized Controlled Trial". The purpose of this study is to determine whether the addition of magnesium to bupivacaine for the post-operative adductor canal blocks (ACB) can decrease opioid consumption and improve pain management for patients after same-day discharge total knee arthroplasty (TKA). The investigators will asses...

What is the current status of trial NCT05004636?

This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2020-08-05. Estimated completion is 2021-05-29.

What conditions does trial NCT05004636 study?

This clinical trial studies the following conditions: Postoperative Pain, Acute.

What interventions are being tested in trial NCT05004636?

The interventions under investigation include: Adding Magnesium as an adjuvant to the adductor canal Block (ACB) for same-day discharge total knee arthroplasty (DRUG).

Who is sponsoring clinical trial NCT05004636?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05004636 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Pain, Acute

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04870762 · 119 participants · Phase 2

    Customized 3D Printed Oral Stents During Head and Neck Radiotherapy

  • NCT05559853 · 119 participants

    Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment

  • NCT06564389 · 119 participants · Phase 1

    FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

  • NCT06742801 · 119 participants · NA

    Onyx™ Liquid Embolic IDE Clinical Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05004636, the US trial registry maintained by the National Library of Medicine. NCT05004636 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.